{"id":155613,"date":"2026-11-20T16:04:48","date_gmt":"2026-11-20T07:04:48","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/4596-20261120-01_wp_share_buyback\/"},"modified":"2026-11-20T16:04:48","modified_gmt":"2026-11-20T07:04:48","slug":"4596-20261120-01_wp_share_buyback","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/","title":{"rendered":"Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)"},"content":{"rendered":"<p>Large-scale exercise of stock acquisition rights occurred. Number of shares delivered is 2,020,000 shares, exercise ratio is 10.1% (against total issued units of 200,000). Between November 11 and November 20 within the period from November 10 to 20, approximately 1,540,700 shares were confirmed exercised, resulting in transferred treasury stock. Outstanding unexercised stock acquisition rights remain at 179,800 units (17,980,000 shares).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4596","jir_company_name":"Kubota Pharmaceutical Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-20","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4596-20261120-01.pdf","jir_short_summary":"Large-scale exercise of stock acquisition rights occurred. Number of shares delivered is 2,020,000 shares, exercise ratio is 10.1% (against total issued units of 200,000). Between November 11 and November 20 within the period from November 10 to 20, approximately 1,540,700 shares were confirmed exercised, resulting in transferred treasury stock. Outstanding unexercised stock acquisition rights remain at 179,800 units (17,980,000 shares).","jir_summary":"### Overview\nKubota Pharmaceutical Holdings Co., Ltd. announced a large-scale exercise of stock acquisition rights issued by third-party allotment. The relevant rights are the 41st series (with an exercise price adjustment clause). From November 10, 2026, the number of shares to be delivered is 2,020,000 shares, and the exercise ratio versus total issued units of 200,000 is 10.1%. Exercise activity from November 10 showed multiple large-scale exercises between November 11 and November 20, with a total of approximately 2,640,000 units exercised. Currently, unexercised stock acquisition rights total 179,800 units (17,980,000 shares) and are recorded as transferred treasury stock. Total shares outstanding are 162,144,288 shares (including 187 treasury shares).\n\n### Impact and Outlook\nShare transfers resulting from the exercise of stock acquisition rights should be considered for potential dilution. However, this document does not provide specific post-exercise financial figures; it only states the remaining unexercised rights. Depending on future exercise activity, shareholder composition and the degree of dilution may change, making additional disclosures important for investment decisions. Further explanation within disclosures is needed to assess accounting impacts and effects on dividend capacity.","jir_financial_highlights":"Number of shares delivered: 2,020,000 shares (Unknown)\nNumber of stock acquisition rights exercised: 60 + 100,000 + 70,000 + 70,000 + 70,000 + 70,000 + 1,250,000 + 320,000 = 2,640,000 units (total during disclosure period) (Unknown)\nTotal shares outstanding (as of 2026-11-09): 162,144,288 shares (Unknown)","jir_category":"","jir_hashtags":"#KubotaPharmaceuticalHoldings, #ExerciseOfCompanyWarrants, #LargeScaleWarrantExercise","jir_key_figures":"Number of shares delivered: 2,020,000 shares\nExercise ratio: 10.1%\nTotal shares outstanding (as of 11\/09): 162,144,288 shares","jir_meta_title":"Kubota Pharmaceutical Holdings Co., Ltd. \u2014 Notice of Large-Scale Exercise of Stock Acquisition Rights | November 2026","jir_meta_description":"Kubota Pharmaceutical Holdings Co., Ltd. announced a large-scale exercise of the 41st stock acquisition rights. Shares delivered: 2,020,000 shares; exercise ratio: 10.1%; outstanding unexercised rights: 179,800 units. Monitor dilution risk and future disclosure.","jir_og_title":"Kubota Pharmaceutical Holdings Co., Ltd. Notice of Large-Scale Exercise of Stock Acquisition Rights","jir_og_description":"Announcement of large-scale exercise of stock acquisition rights. Shares delivered: 2,020,000 shares; exercise ratio: 10.1%; outstanding unexercised rights: 179,800 units. Monitor future impact and disclosure developments.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59981,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-155613","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause) - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/\",\"name\":\"Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause) - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-11-20T07:04:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause) - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/","url":"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/","name":"Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause) - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-11-20T07:04:48+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4596\/ir\/4596-20261120-01_wp_share_buyback\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"59981","title":"KUBOTA PHARMACEUTICAL HLDGS CO","ticker":"4596"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/155613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=155613"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/155613\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=155613"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=155613"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=155613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}